Follow-up Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-L) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Follow-up Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-L)	Arterial Occlusive Diseases, Chronic Disease, Chronic Limb-Threatening Ischemia, Diabetes Complications, Diabetic Foot, Disease Attributes, Foot Ulcer, Leg Ulcer, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin Ulcer, Skin and Connective Tissue Diseases, arteriosclerosis disorder, arteriosclerosis obliterans, atherosclerosis, cardiovascular disorder, diabetes mellitus, diabetic neuropathy, diabetic peripheral angiopathy, endocrine system disorder, ischemic disease, peripheral arterial disease, peripheral vascular disease, skin disorder, thromboangiitis obliterans, vascular disorder, vasculitis	Enrolling by invitation	Not stated	2025-07-11		NCT07023965

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Beijing Northland Biotech. Co., Ltd.	3

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Chifeng Municipal Hospital	Chifeng	China	3
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences	Beijing	China	3
The First Affiliated Hospital of Xi 'an Jiaotong University	Xi'an	China	5
The first affiliated hospital, Zhejiang university school of medicine	Hangzhou	China	27
zhongshan Hospital Affiliated of Dalian University	Dalian	China	1